Meta-analysis of the adverse events associated with extended-release versus standard immediate-release pramipexole in Parkinson disease

BACKGROUND: In order to increase treatment choices for patients with Parkinson disease (PD), we performed a retrospective assessment of adverse events associated with a novel once-daily extended-release (ER) formulation versus the standard immediate-release (IR) of the nonergolinic dopamine agonist,...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zhengze, Kong, Deping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112990/
https://www.ncbi.nlm.nih.gov/pubmed/30142750
http://dx.doi.org/10.1097/MD.0000000000011316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6112990/
https://www.ncbi.nlm.nih.gov/pubmed/30142750
http://dx.doi.org/10.1097/MD.0000000000011316

Ejemplares similares